Back-To-Back FDA Approvals For Roche's Two Under-The-Skin Injections
The FDA has approved Roche's Ocrevus Zunovo for relapsing and primary progressive multiple sclerosis, offering the first ...
Pharmaceutical Technology3d
After the Lykos debacle, what’s next for psychedelic therapies?
While Lykos Therapeutics’ MDMA therapy was rejected by the FDA, psychedelic therapy advocates remain optimistic about the ...
Medscape3d
FDA OKs Subcutaneous Atezolizumab Formulation for Multiple Cancer Indications
The US Food and Drug Administration (FDA) has approved atezolizumab and hyaluronidase-tqjs (Tecentriq Hybreza, Genentech, Inc ...
Cancer Therapy Advisor4d
FDA Approves Tecentriq Hybreza
Tecentriq Hybreza is supplied in a single-dose vial containing 1875 mg of atezolizumab and 30,000 units of hyaluronidase per 15 mL. The US Food and Drug Administration (FDA) has approved Tecentriq ...
Pharmabiz5d
Halozyme announces US FDA approval of Roche's Tecentriq Hybreza with Enhanze for multiple types of cancer
Halozyme announces US FDA approval of Roche's Tecentriq Hybreza with Enhanze for multiple types of cancer: San Diego Saturday, September 14, 2024, 12:00 Hrs [IST] Halozyme Therape ...
MedPage Today5d
Trump's IVF Pledge; Nurse Rescues Trapped Man; Who's Getting Vaccinated?
Emergency department nurse Miles Crawford, 39, rescued a man trapped in floodwaters in New Orleans following Hurricane ...
Monthly Prescribing Reference6d
FDA Approves Tecentriq Hybreza, a Subcutaneously Administered PD-L1 Inhibitor
The Food and Drug Administration (FDA) has approved Tecentriq Hybreza ™ (atezolizumab and hyaluronidase-tqjs) for subcutaneous (SC) injection, for all the approved adult indications of intravenous ...
Swiss Market Ends Higher For 2nd Straight Day
The Switzerland market closed higher on Friday, tracking positive cues from other European markets amid hopes the Federal Reserve ...
FiercePharma6d
Roche doubles down with another subcutaneous FDA nod, this one for MS star Ocrevus
When Roche's Genentech gained approval for Ocrevus in 2017, the first-in- | On the same day that Roche gained an FDA approval ...
Roche Gets FDA Approval for Subcutaneous Formulation of Tecentriq
The FDA approves subcutaneous formulation of RHHBY's leading immunotherapy drug, Tecentriq, under the brand name Tecentriq ...
FiercePharma6d
After delay, Roche's Tecentriq Hybreza wins first FDA approval for a subcutaneous PD-L1 drug
It’s better late than never for an FDA approval for the first subcutaneous PD-L1 inhibitor, which was doled out to Roche’s ...